Viking Therapeutics
VKTX
VKTX
421 hedge funds and large institutions have $5.25B invested in Viking Therapeutics in 2024 Q3 according to their latest regulatory filings, with 94 funds opening new positions, 178 increasing their positions, 101 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
23% more capital invested
Capital invested by funds: $4.26B → $5.25B (+$987M)
9% more funds holding
Funds holding: 386 → 421 (+35)
2.82% more ownership
Funds ownership: 72.93% → 75.75% (+2.8%)
Holders
421
Holding in Top 10
8
Calls
$464M
Puts
$242M
Top Buyers
| 1 | +$68.9M | |
| 2 | +$63.7M | |
| 3 | +$62M | |
| 4 |
Morgan Stanley
New York
|
+$58.7M |
| 5 |
PL
Perpetual Ltd
Sydney, New South Wales,
Australia
|
+$28.6M |
Top Sellers
| 1 | -$58.1M | |
| 2 | -$40.9M | |
| 3 | -$40M | |
| 4 |
Millennium Management
New York
|
-$34.9M |
| 5 |
State Street
Boston,
Massachusetts
|
-$28.4M |